Literature DB >> 7020378

Carrageenan: a review of its effects on the immune system.

A W Thomson, E F Fowler.   

Abstract

Carrageenans (kappa, lambda and iota) are sulphated polysaccharides isolated from marine algae that can markedly suppress immune responses both in vivo and in vitro. Impairment of complement activity and humoral responses to T-dependent antigens, depression of cell-mediated immunity, prolongation of graft survival and potentiation of tumour growth by carrageenans have been reported. The mechanism responsible for carrageenan-induced immune suppression is believed to be its selective cytopathic effect on macrophages. This property of carrageenan has led to its adoption as a tool for analysing the role of these cells in the induction and expression of immune reactivity. Systemic administration of carrageenan may, however, induce disseminated intravascular coagulation and inflict damage on both the liver and kidney. This is an important consideration in the interpretation of the effects of carrageenan in vivo and precludes its use as a clinical immune suppressant.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020378     DOI: 10.1007/bf01967625

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  71 in total

1.  THE INTERACTION BETWEEN CARRAGEENAN AND THE FIRST COMPONENT OF COMPLEMENT.

Authors:  T BORSOS; H J RAPP; C CRISLER
Journal:  J Immunol       Date:  1965-05       Impact factor: 5.422

2.  Modification of lymphocyte responsiveness in vitro by lambda carrageenan compared with colloidal silica and depletion of surface adherent cells.

Authors:  G Pawelec; G Brons
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

3.  Promotion of tumor growth in vivo by antimacrophage agents.

Authors:  R Keller
Journal:  J Natl Cancer Inst       Date:  1976-12       Impact factor: 13.506

4.  Tolerance induction with bovine gamma globulin in mouse radiation chimaeras depends on macrophages.

Authors:  M L Lukic; S Leskowitz
Journal:  Nature       Date:  1974-12-13       Impact factor: 49.962

5.  The immunodepressant effect of carrageenin.

Authors:  L Aschheim; S Raffel
Journal:  J Reticuloendothel Soc       Date:  1972-03

6.  Alleviation of carrageenan-induced hepatotoxicity and acronecrosis by aprotinin.

Authors:  E F Fowler; A W Thomson; C H Horne
Journal:  Br J Exp Pathol       Date:  1977-06

7.  Effect of carrageenan on activity of the mononuclear phagocyte system in the mouse.

Authors:  E F Fowler; A W Thomson
Journal:  Br J Exp Pathol       Date:  1978-04

8.  Changes in thymocyte reactivity to lectins induced by B-cell mitogens of the type of sulphated polyanions.

Authors:  E Blitstein-Willinger; G Schulz; T Diamantstein
Journal:  Immunology       Date:  1976-04       Impact factor: 7.397

9.  Pharmacological immunosuppression in clinical organ grafting. Observations on four agents: cyclosporin A, Asta 5122 (cytimun), lambda carrageenan and promethazine hydrochloride.

Authors:  R Y Calne
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

10.  A histopathological study of the effects of intravenously administered lambda carrageenan in the mouse, with particular reference to the macrophage system.

Authors:  P R Steele; J R Lowes
Journal:  Br J Exp Pathol       Date:  1979-08
View more
  20 in total

Review 1.  Toxicological properties of carrageenan.

Authors:  M L Weiner
Journal:  Agents Actions       Date:  1991-01

2.  Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice.

Authors:  S Bhattacharyya; I O-Sullivan; S Katyal; T Unterman; J K Tobacman
Journal:  Diabetologia       Date:  2011-10-20       Impact factor: 10.122

3.  Inhibition of tumor metastasis by carrageenan-induced granulomas.

Authors:  W J Kort; A M Bijma; I M Hekking
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

4.  Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae.

Authors:  H Nakashima; Y Kido; N Kobayashi; Y Motoki; M Neushul; N Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

5.  Growth disturbances in experimental juvenile arthritis of the dog knee.

Authors:  C Bunger; E H Bunger; S Harving; J C Djurhuus; O M Jensen
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

6.  Fcγ receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1.

Authors:  Rahul Mittal; Sunil K Sukumaran; Suresh K Selvaraj; David G Wooster; M Madan Babu; Alan D Schreiber; J Sjef Verbeek; Nemani V Prasadarao
Journal:  PLoS Pathog       Date:  2010-11-18       Impact factor: 6.823

7.  Macrophage-mediated suppression of T lymphocyte proliferation induced by oral carrageenan administration.

Authors:  F R Cochran; C S Baxter
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

8.  Some characteristics of the in vivo antitumor immunity exhibited by mice cured of a large MOPC-315 tumor by a low dose of melphalan.

Authors:  E Barker; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

9.  Selective inhibition of cell proliferation and DNA synthesis by the polysulphated carbohydrate l-carrageenan.

Authors:  R Hoffman; W W Burns; D H Paper
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 10.  Recent Advances in Chemically-Modified and Hybrid Carrageenan-Based Platforms for Drug Delivery, Wound Healing, and Tissue Engineering.

Authors:  Hamidreza Mokhtari; Shima Tavakoli; Fereshteh Safarpour; Mahshid Kharaziha; Hamid Reza Bakhsheshi-Rad; Seeram Ramakrishna; Filippo Berto
Journal:  Polymers (Basel)       Date:  2021-05-26       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.